Document ID: chunk:federal_register_of_legislation:F2022L00655:reg:9
Version: federal_register_of_legislation:F2022L00655
Segment Type: reg
Provision Reference: reg 9
Character Range: 4497–7293

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the thyroid gland or death from malignant neoplasm of the thyroid gland with the circumstances of a person's relevant service:
(1)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the thyroid gland at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
(2)          having received a cumulative equivalent dose of at least 0.05 sievert of ionising radiation to the thyroid gland by the age of 20 years and at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
(3)          having iodine-131 (radioactive iodine) therapy at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
(4)          being overweight or obese for at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
Note: being overweight or obese is defined in the Schedule 1 – Dictionary.
(5)          having a thyroid condition from the specified list of thyroid conditions at the time of the clinical onset of malignant neoplasm of the thyroid gland;
Note: specified list of thyroid conditions is defined in the Schedule 1 – Dictionary.
(6)          having acromegaly before the clinical onset of malignant neoplasm of the thyroid gland;
Note: acromegaly is defined in the Schedule 1 - Dictionary.
(7)          having diabetes mellitus for at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
(8)          having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of malignant neoplasm of the thyroid gland;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(9)          undergoing organ or tissue transplantation, excluding corneal transplant, before the clinical onset of malignant neoplasm of the thyroid gland;
Note: organ or tissue transplantation is defined in the Schedule 1 – Dictionary.
(10)      for parous women only, inability to breast feed for a cumulative period of at least 6 months before the clinical onset of malignant neoplasm of the thyroid gland;
Note: The period of breastfeeding could be cumulative over a number of pregnancies.
(11)      taking clomiphene at least 5 years before the clinical onset of malignant neoplasm of the thyroid gland;
(12)      inability to obtain appropriate clinical management for malignant neoplasm of the thyroid gland.